These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Haemodynamic effects of dobutamine in patients with coronary artery disease. Magnani B, Ambrosioni E, Branzi A, Picchio F, Capitanucci P. J Int Med Res; 1977 Sep; 5(1):10-7. PubMed ID: 838109 [Abstract] [Full Text] [Related]
33. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure. Jamison M, Widerhorn J, Weber L, Campese V, Vasquez J, Hovanessian L, Rahimtoola SH, Elkayam U. Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556 [Abstract] [Full Text] [Related]
34. Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse. Francis GS, Sharma B, Hodges M. Am Heart J; 1982 Jun; 103(6):995-1000. PubMed ID: 7081040 [Abstract] [Full Text] [Related]
36. Functional and metabolic effects of bucladesine (dibutyryl cyclic AMP) in the working rat heart preparation: comparison with dopamine. Hashimoto H, Kunitada S, Tamura K. Arch Int Pharmacodyn Ther; 1989 Jun; 301():200-14. PubMed ID: 2560364 [Abstract] [Full Text] [Related]